| 前收市價 | 30.60 |
| 開市 | 30.40 |
| 買盤 | 31.00 x 無 |
| 賣出價 | 31.80 x 無 |
| 今日波幅 | 30.40 - 30.40 |
| 52 週波幅 | 16.60 - 38.40 |
| 成交量 | |
| 平均成交量 | 0 |
| 市值 | 無 |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | 無 |
| 業績公佈日 | 2024年8月08日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
ZacksWill PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know
PTC Therapeutics (PTCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksPTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
PTC Therapeutics (PTCT) falls as the EC's advisory committee adopts a negative opinion regarding the renewal of the conditional marketing approval of Translarna to treat nmDMD in the EU.
Investor's Business DailyPTC's Journey Of 'Twist And Doubt' Continues With Another Rejection; Shares Tumble
European regulators rejected PTC Therapeutics' Duchenne muscular dystrophy drug — again — sending PTC stock into free fall early Friday.
